Inhibition of Furin-like Enzymes Blocks Interleukin-1alpha/oncostatin M-stimulated Cartilage Degradation
Overview
Authors
Affiliations
Objective: To investigate the role of furin-like enzymes in the proteolytic cascades leading to cartilage breakdown and to examine which collagenase(s) contribute to collagen degradation.
Methods: Bovine nasal cartilage was stimulated to resorb with the addition of interleukin-1alpha (IL-1alpha)/oncostatin M (OSM) in the presence or absence of a furin inhibitor, Dec-RVKR-CH(2)Cl, or selective matrix metalloproteinase 1 (MMP-1) inhibitors. Collagen and proteoglycan levels were determined by assay of hydroxyproline and sulfated glycosaminoglycan, respectively. Collagenase and gelatinase activity were measured using (3)H-acetylated collagen and gelatin zymography, respectively.
Results: The addition of Dec-RVKR-CH(2)Cl to stimulated cartilage reduced the release of collagen fragments and the levels of active collagenase and MMP-2, suggesting that furin-like enzymes are involved in the cascades leading to activation of procollagenases. At MMP inhibitor concentrations that selectively inhibit MMP-1, no inhibition of collagen release was observed, but increasing the concentration to the 50% inhibition concentration for MMP-13 resulted in a 50% blockage of collagen release. The addition of Dec-RVKR-CH(2)Cl to resorbing cartilage also partially blocked proteoglycan release, thus demonstrating a role for furin-activated enzymes in the pathways leading to proteoglycan degradation.
Conclusion: Furin-like enzymes are involved in cascades leading to activation of procollagenases and degradation of collagen. MMP-13, which can be activated by furin-processed membrane-type 1 MMP-1, appears to be a major collagenase involved in collagen degradation induced by IL-1alpha/OSM. Furin-like enzymes also appear to play a role in the pathways leading to proteoglycan degradation. These findings are of importance when considering proteinase inhibition as a target for therapeutic intervention in arthritic diseases.
Chen M, Wang M, Shen X, Liu H, Zhang Y, Peng J J Virol. 2022; 96(20):e0131822.
PMID: 36173190 PMC: 9599266. DOI: 10.1128/jvi.01318-22.
Recent advances in understanding the regulation of metalloproteinases.
Young D, Barter M, Wilkinson D F1000Res. 2019; 8.
PMID: 30828429 PMC: 6381797. DOI: 10.12688/f1000research.17471.1.
Lin H, Hay E, Latourte A, Funck-Brentano T, Bouaziz W, Ea H Sci Rep. 2018; 8(1):10488.
PMID: 29992982 PMC: 6041273. DOI: 10.1038/s41598-018-28713-2.
Wilkinson D, Arques M, Huesa C, Rowan A Br J Pharmacol. 2018; 176(1):38-51.
PMID: 29473950 PMC: 6284380. DOI: 10.1111/bph.14173.
Wilkinson D, Desilets A, Lin H, Charlton S, Arques M, Falconer A Sci Rep. 2017; 7(1):16693.
PMID: 29196708 PMC: 5711915. DOI: 10.1038/s41598-017-17028-3.